Theraclone In the News

Media professionals who wish to learn more about Theraclone’s technology and areas of research and development, please contact us at:

Access recent media coverage of Theraclone via the links below.

Theraclone Namess Cliff Stocks, Vet of Icos & Calistoga, as New CEO
Xconomy, December 6, 2011

Theraclone Enters Clinical World, With Flu Antibody That Might Be Handy in Pandemic
Xconomy, September 21, 2011

Theraclone has Flu Therapy Ready for Human Trials
Puget Sound Business Journal, September 21, 2011

Therclone Sciences Taps Insiders for $10.6M Series B Extension
Dow Jones VentureWire Lifescience, September 9, 2011

Theraclone Snaps Up $10.6M Financing
Xconomy, September 8, 2011

Theraclone Sciences – 2011 Fierce 15
FierceBiotech, September 6, 2011

Scientists Spot New Antibodies Against HIV, Opening Up Potential Path to AIDS Vaccine
Xconomy, August 17, 2011

Pfizer in Deal With Theraclone for Antibody Drug Research
New York Times, January 18, 2011

Theraclone Strikes $632M Deal With Pfizer to Discover Antibodies for Cancer Infections
Xconomy, January 18, 2011

Influenza matrix protein 2 extracellular domain (M2e)
SciBX, July 15, 2010

Rodent of the week: closing in on a universal flu vaccine
Los Angeles Times Blog, July 2, 2010

Theraclone makes a breakthrough on universal flu vax
FierceVaccines, June 30, 2010

Researchers find rare flu antibodies
Edmonton Journal, June 29, 2010

Study finds body's potential universal flu defense
Reuters, June 28, 2010

Seattle's Theraclone makes a 'first step' on long road to universal flu vaccine
Seattle Times, June 28, 2010

Seattle company of verge of universal flu vaccine, June 28, 2010

Flu Vaccines Hit a Wall
Technology Review, October 13, 2009

Antibodies found that prevent HIV from causing severe AIDS
Los Angeles Times, September 4, 2009

Biotech-assisted antibody discovery may lead to AIDS vaccine
Fierce Biotech, September 4, 2009

Discovery Of New HIV Antibodies Opens Door To Effective AIDS Vaccine
Medical News Today, September 4, 2009

Study finds potential way to make an AIDS vaccine
Reuters, September 3, 2009

Powerful HIV-Blocking Antibodies Raise New Hopes for Vaccine
Bloomberg, September 3, 2009

Discoveries Brighten Search for AIDS Vaccine
HealthDay News, September 3, 2009

Antibodies 'may aid HIV jab hunt'
BBC News, September 3, 2009

A fluttering in the breeze
The Economist, September 3, 2009

Unique antibodies may be the key for AIDS vaccine
The Globe and Mail News, September 3, 2009

Antibodies for HIV, Long Dismissed, Show Signs of Comeback at Seattle's Theraclone, April 7, 2009

Biotech firm attracts $29 million in 2nd funding round
Seattle Times, March 17, 2007

$29 million gives biotech Spaltudaq funds to grow
Seattle Post-Intelligencer, March 17, 2007

New biotech Spaltudaq has different take on cancer fight
Seattle Post-Intelligencer, January 24, 2005

Startup targets tumor weapons
Seattle Times, January 24, 2005